STOCKSEngaged Takes Stakes in Cross Country Health, Finisar and other companiesBy Ronald OrolMay 16, 2018 9:09 AM EDT
HEALTHBiotech Movers: Aratana Offering Priced Below Market, Shares FallBy Armie Margaret LeeMay 4, 2017 9:25 AM EDT
HEALTHBiotech Premarket Movers: Editas, Amphastar, Aratana, PaciraBy Armie Margaret LeeMar 14, 2017 9:26 AM EDT
INVESTINGOne of the Biggest Challenges of the Market Since Last SummerBy James "Rev Shark" DePorreFeb 6, 2017 4:25 PM EST
MARKETSWall Street Lower As Investors' Digest Trump's Political MovementsBy Valerie YoungFeb 6, 2017 4:08 PM EST
STOCKSBiotech premarket movers: Cytokinetics, Artana Therapeutics, BluebirdBy Sarah PringleFeb 6, 2017 9:29 AM EST
JIM CRAMER'Mad Money' Lightning Round: Abbvie Is a Great Long-Term PositionBy Scott RuttSep 13, 2016 6:00 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: Why You Shouldn't Be Jumping In and Out of StocksBy Scott RuttSep 12, 2016 8:20 PM EDT
JIM CRAMER'Mad Money' Lightning Round: Lockheed Martin Can Fly to $210By Scott RuttAug 31, 2016 6:00 AM EDT
JIM CRAMERJim Cramer's 'Mad Money' Recap: The Urge to Merge Rules Wall StreetBy Scott RuttAug 30, 2016 8:30 PM EDT
MARKETSAratana Therapeutics (PETX) Is Strong On High Volume TodayBy TheStreet WireJun 2, 2016 10:00 AM EDT
MARKETSAratana Therapeutics (PETX) Is Strong On High Volume TodayBy TheStreet WireMay 11, 2016 10:02 AM EDT
MARKETSAratana Therapeutics (PETX) Stock: Weak On High Volume TodayBy TheStreet WireApr 8, 2016 10:06 AM EDT
MARKETSAratana Therapeutics (PETX) Is Today's Strong On High Volume StockBy TheStreet WireApr 6, 2016 10:04 AM EDT
MARKETSAratana Therapeutics (PETX) Stock Jumps Ahead of Drug Data PresentationBy Kaya YurieffMar 31, 2016 2:28 PM EDT
MARKETSStrong On High Relative Volume: Aratana Therapeutics (PETX)By TheStreet WireMar 23, 2016 10:20 AM EDT
